Publications by authors named "Katia Lopez Revuelta"
Background: Up to 50-60% of patients with diabetes have non-diabetic kidney disease (NDKD) on kidney biopsy. Diabetic retinopathy (DR) is a microvascular complication of diabetes frequently associated with diabetic nephropathy (DN). The objective of the current study was to investigate the kidney outcomes and survival in patients with biopsy diagnoses of DN and NDKD according to the presence of DR.
View Article and Find Full Text PDFIntroduction: Macroscopic hematuria (MH) bouts, frequently accompanied by acute kidney injury (AKI-MH) are one of the most common presentations of IgA nephropathy (IgAN) in the elderly. Immunosuppressive therapies are used in clinical practice; however, no studies have analyzed their efficacy on kidney outcomes.
Methods: This is a retrospective, multicenter study of a cohort of patients aged ≥50 years with biopsy-proven IgAN presenting with AKI-MH.
Introduction: There is an increased risk of thrombotic complications in patients with COVID-19. Hemodialysis patients are already at an increased risk for thromboembolic events such as stroke and pulmonary embolism. The aim of our study was to determine the incidence of late thrombotic complications (deep vein thrombosis, pulmonary embolism, stroke, new-onset vascular access thrombosis) in maintenance hemodialysis patients after recovery from COVID-19.
View Article and Find Full Text PDFBackground: Diabetic patients with kidney disease have a high prevalence of non-diabetic renal disease (NDRD). Renal and patient survival regarding the diagnosis of diabetic nephropathy (DN) or NDRD have not been widely studied. The aim of our study is to evaluate the prevalence of NDRD in patients with diabetes and to determine the capacity of clinical and analytical data in the prediction of NDRD.
View Article and Find Full Text PDFIgA Nephropathy in Elderly Patients.
Clin J Am Soc Nephrol
August 2019
Article Synopsis
- The study investigates the increasing incidence of IgA nephropathy among older adults (aged ≥65) and analyzes various clinical aspects of the disease based on a cohort of 151 patients diagnosed between 1990 and 2015.
- Researchers observed a significant rise in diagnoses over the years, with common symptoms including asymptomatic urinary issues and acute kidney injury (AKI), particularly related to hematuria.
- The study found that age, serum creatinine levels, and kidney biopsy findings were linked to worse outcomes, while treatment with specific medications showed potential benefits for survival rates.
Diabetic nephropathy without diabetes (DNND), previously known as idiopathic nodular glomerulosclerosis, is an uncommon entity and thus rarely suspected; diagnosis is histological once diabetes is discarded. In this study we describe two new cases of DNND and review the literature. We analyzed all the individualized data of previous publications except one series of attached data.
View Article and Find Full Text PDFC3 glomerulonephritis is a clinicopathologic entity defined by the presence of isolated or dominant deposits of C3 on immunofluorescence. To explore the effect of immunosuppression on C3 glomerulonephritis, we studied a series of 60 patients in whom a complete registry of treatments was available over a median follow-up of 47 months. Twenty patients had not received immunosuppressive treatments.
View Article and Find Full Text PDFAim: To examine the risk of renal events in patients with biopsy-proven diabetic nephropathy (DN) and its possible associated factors.
Methods: Clinical and histological data of 60 patients diagnosed with diabetic nephropathy were retrospectively collected. Patients with evidence or suspicion of other nephropathies were excluded from the study.
Article Synopsis
- Diabetes mellitus (DM) is a major cause of end-stage renal disease (ESRD) and necessitates comparison between diabetic and non-diabetic patient cohorts starting dialysis.
- In a study involving 232 diabetic patients (mostly type 2) and 121 non-diabetic patients, results showed diabetic patients had worse health perceptions, functional status, and were more likely to face hypertension and cardiovascular complications.
- The conclusion indicates that diabetic patients in Spain starting dialysis exhibit lower quality of life and worse health outcomes compared to non-diabetic patients.
Background: Health-related quality of life may affect morbidity and survival in end-stage renal disease, but it is not clear whether coexisting comorbidity and other known prognostic variables could account for such an association.
Methods: To study the relationship between health-related quality of life and morbidity and survival, we carried out an inception cohort study in patients starting chronic dialysis, mostly diabetics, with a follow-up of 1-3 years in 34 Spanish hospitals. Health-related quality of life was measured by the SF-36 Health Survey and Karnofsky scale.